Skip to content
OpenCapital
Get started

Ensysce Biosciences, Inc. ENSC Q4 2024 Annual earnings

Reported March 10, 2025 · Before market open

Revenue$1.3MBeat by $1.1M
EPS-$2.90Miss by $0.16
Revenue estimate$245.0K
EPS estimate-$2.74

Next report

Aug 12, 2026 (In 2 weeks)
Revenue estimate$1.9M
EPS estimate-$0.50

Versus estimates

Revenue

Q1 2026$961.0KMiss by $39.0KQ4 2025$1.9MBeat by $1.4MQ3 2025$493.1KMiss by $206.9KQ2 2025$1.4MMiss by $27.4KQ1 2025$1.3M
Q4 2024$1.3MBeat by $1.1M

Diluted EPS

Q1 2026-$0.52In lineQ4 2025-$0.75Beat by $0.51Q3 2025-$1.29Miss by $0.44Q2 2025-$0.79Beat by $0.23Q1 2025-$1.39Beat by $1.63
Q4 2024-$2.90Miss by $0.16

Ask the moment Ensysce Biosciences, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Ensysce Biosciences, Inc. report Q4 2024 earnings?
Ensysce Biosciences, Inc. (ENSC) reported Q4 2024 earnings on March 10, 2025 before market open.
What were Ensysce Biosciences, Inc.'s Q4 2024 revenue and EPS?
Ensysce Biosciences, Inc. reported revenue of $1.3M and eps of $-2.90 for Q4 2024.
Did Ensysce Biosciences, Inc. beat estimates in Q4 2024?
Revenue beat the consensus estimate of $245.0K by $1.1M. EPS missed the consensus estimate of $-2.74 by $0.16.
Where can I find Ensysce Biosciences, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001493152-25-009703) directly on SEC EDGAR. The filing index links above go to sec.gov.